INMED PHARMACEUTICALS (Germany) Probability of Future Stock Price Finishing Over 3.75
| MWG0 Stock | 4.17 0.00 0.00% |
INMED |
INMED PHARMACEUTICALS Target Price Odds to finish over 3.75
The tendency of INMED Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above 3.75 in 90 days |
| 4.17 | 90 days | 3.75 | about 78.63 |
Based on a normal probability distribution, the odds of INMED PHARMACEUTICALS to stay above 3.75 in 90 days from now is about 78.63 (This INMED PHARMACEUTICALS INC probability density function shows the probability of INMED Stock to fall within a particular range of prices over 90 days) . Probability of INMED PHARMACEUTICALS INC price to stay between 3.75 and its current price of 4.17 at the end of the 90-day period is about 23.57 .
Assuming the 90 days trading horizon INMED PHARMACEUTICALS INC has a beta of -2.81. This indicates as returns on its benchmark rise, returns on holding INMED PHARMACEUTICALS INC are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, INMED PHARMACEUTICALS is expected to outperform its benchmark. Additionally INMED PHARMACEUTICALS INC has an alpha of 0.4893, implying that it can generate a 0.49 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). INMED PHARMACEUTICALS Price Density |
| Price |
Predictive Modules for INMED PHARMACEUTICALS
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as INMED PHARMACEUTICALS INC. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.INMED PHARMACEUTICALS Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. INMED PHARMACEUTICALS is not an exception. The market had few large corrections towards the INMED PHARMACEUTICALS's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold INMED PHARMACEUTICALS INC, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of INMED PHARMACEUTICALS within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.49 | |
β | Beta against Dow Jones | -2.81 | |
σ | Overall volatility | 0.63 | |
Ir | Information ratio | 0.04 |
INMED PHARMACEUTICALS Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of INMED PHARMACEUTICALS for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for INMED PHARMACEUTICALS INC can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| INMED PHARMACEUTICALS is way too risky over 90 days horizon | |
| INMED PHARMACEUTICALS appears to be risky and price may revert if volatility continues |
INMED PHARMACEUTICALS Technical Analysis
INMED PHARMACEUTICALS's future price can be derived by breaking down and analyzing its technical indicators over time. INMED Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of INMED PHARMACEUTICALS INC. In general, you should focus on analyzing INMED Stock price patterns and their correlations with different microeconomic environments and drivers.
INMED PHARMACEUTICALS Predictive Forecast Models
INMED PHARMACEUTICALS's time-series forecasting models is one of many INMED PHARMACEUTICALS's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary INMED PHARMACEUTICALS's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about INMED PHARMACEUTICALS INC
Checking the ongoing alerts about INMED PHARMACEUTICALS for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for INMED PHARMACEUTICALS INC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| INMED PHARMACEUTICALS is way too risky over 90 days horizon | |
| INMED PHARMACEUTICALS appears to be risky and price may revert if volatility continues |
Other Information on Investing in INMED Stock
INMED PHARMACEUTICALS financial ratios help investors to determine whether INMED Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in INMED with respect to the benefits of owning INMED PHARMACEUTICALS security.